Endocannabinoid System Clinical Research: CBD & Metabolic Health Insights
This pilot study examined cannabidiol glucose tolerance clinical trial evidence in sedentary adults with overweight or obesity. Results showed short-term low-dose CBD did not improve glucose tolerance or alter gut microbiome composition. These findings…
Cannabinoid Clinical Trials: Cannabis for Chronic Back Pain
This phase 3 trial evaluated the full-spectrum cannabis extract chronic low back pain treatment in 820 adults. Results showed significant pain reduction and sustained benefits. The full-spectrum cannabis extract chronic low back pain trial offers new…
Cannabinoid Clinical Trials: Cannabis for Insomnia EEG
This pilot trial studied acute effects oral cannabinoids sleep EEG in 20 adults with insomnia. The combination of 10 mg THC and 200 mg CBD reduced total sleep time compared to placebo. These findings highlight the need for cautious interpretation of…
Endocannabinoid System Clinical Research: 2024 RCT Review
This 2024 RCT review highlights digital mental health intervention cannabis research focusing on the Minder mobile app. The study evaluates its impact on university students' mental health and substance use. Digital tools like this are promising for…
Endocannabinoid System Clinical Research: CBD & Metabolism Analysis
This cannabidiol glucose tolerance clinical research evaluates the impact of low-dose CBD supplementation on metabolic health. The study found no significant improvements in glucose tolerance or gut microbiome composition. These findings highlight the…
AM Policy Update: DEA Synthetic Opioids Schedule I Placement
The DEA synthetic opioids schedule I placement update on March 17, 2026, highlights key regulatory changes. This update covers multiple synthetic opioids classified under Schedule I. These changes impact controlled substance regulations and cannabis…
AM Study Update: Full-Spectrum Cannabis Extract for Chronic Pain
This AM Study Update covers the latest research on full-spectrum cannabis extract chronic pain treatment. The phase 3 trial of Cannabis sativa extract DKJ127 shows promising results for chronic low back pain. Clinicians can use this evidence to guide…
AM News Update: March 17, 2026 – Cannabis Clinical Trials & Mental Health
This AM News Update covers cannabis clinical trials mental health research from March 17, 2026. It highlights recent studies on cannabis efficacy and safety for mental disorders. The update emphasizes the need for rigorous dose-finding studies and…
Cannabis Use and Trauma-Focused Treatment for PTSD & Substance Use
Cannabis use trauma-focused treatment PTSD is crucial for individuals with co-occurring substance use disorders. Evidence shows cannabis does not undermine PTSD treatment effectiveness. Trauma-focused treatments remain beneficial even with cannabis use.
Research Digest: 20 Recent Studies (D) – March 16, 2026
This recent cannabis research digest presents 20 peer-reviewed studies curated for clinical relevance and evidence quality. The digest covers diverse topics including cannabis use in endometriosis, rheumatology, and adolescent mental health. Stay…